Management to Host Investor Conference Call Tomorrow, Friday, January 27 at 8:45 a.m. ET
Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source
January 27, 2012 By Leave a Comment